Masaru Katoh

Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 9

Top Venues

Nature reviews. Clinical oncology

Clinical and translational medicine

Essays in biochemistry

Clinical science (London, England : 1979)

National Cancer Center

University of Tokyo (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

National Cancer Center

Japan

Chief :: Department of Omics Network

National Cancer Centre

Japan

Chief :: Katoh's Unit

Toranomon Hospital

Japan

Physician :: Department of Gastroenterology

Education History

University of Tokyo

Japan

PHD :: Graduate School of Medicine

Publications

Masuko Katoh, Natacha Naoun, Giovanni Brandi, Simona Tavolari, Zev A Wainberg, Masaru Katoh
FGFR-targeted therapeutics: clinical activity, mechanisms of resistance and new directions. Nature reviews. Clinical oncology 21 (4) (2024)
Masuko Katoh, Izuma Nakayama, Zev A Wainberg, Kohei Shitara, Masaru Katoh
Monoclonal antibodies that target fibroblast growth factor receptor 2 isoform b and Claudin-18 isoform 2 splicing variants in gastric cancer and other solid tumours. Clinical and translational medicine 14 (6) (2024)
Masuko Katoh, Natacha Naoun, Giovanni Brandi, Simona Tavolari, Zev A Wainberg, Masaru Katoh
FGFR-targeted therapeutics: clinical activity, mechanisms of resistance and new directions. Nature reviews. Clinical oncology (2024)
Masuko Katoh, Natacha Naoun, Giovanni Brandi, Simona Tavolari, Zev A Wainberg, Masaru Katoh
FGFR-targeted therapeutics: clinical activity, mechanisms of resistance and new directions. Nature reviews. Clinical oncology (2024)
Masuko Katoh, Izuma Nakayama, Zev A Wainberg, Kohei Shitara, Masaru Katoh
Monoclonal antibodies that target fibroblast growth factor receptor 2 isoform b and Claudin-18 isoform 2 splicing variants in gastric cancer and other solid tumours. Clinical and translational medicine 14 (6) (2024)
Masuko Katoh, Natacha Naoun, Giovanni Brandi, Simona Tavolari, Zev A Wainberg, Masaru Katoh
FGFR-targeted therapeutics: clinical activity, mechanisms of resistance and new directions. Nature reviews. Clinical oncology 21 (4) (2024)
Masuko Katoh, Izuma Nakayama, Zev A Wainberg, Kohei Shitara, Masaru Katoh
Monoclonal antibodies that target fibroblast growth factor receptor 2 isoform b and Claudin-18 isoform 2 splicing variants in gastric cancer and other solid tumours. Clinical and translational medicine 14 (6) (2024)
Masuko Katoh, Masaru Katoh
WNT signaling and cancer stemness. Essays in biochemistry 66 (4) (2022)
Masaru Katoh
Genomic testing, tumor microenvironment and targeted therapy of Hedgehog-related human cancers. Clinical science (London, England : 1979) 133 (8) (2019)

Masaru Katoh.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Masaru Katoh